← Browse by Condition
Medical Condition

hormone receptor positive her 2 negative breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05901428 Phase 3
Recruiting

TCb vs EC-T in High Risk ER+/HER2- Breast Cancer

Enrollment
1,736 pts
Location
China
Sponsor
Fudan University
View Trial →